{
    "nctId": "NCT05931302",
    "briefTitle": "Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT",
    "officialTitle": "Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT",
    "overallStatus": "RECRUITING",
    "conditions": "Lobular Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Number of positive tumor lesions, i.e. confirmed by additional imaging, histopathology/biopsy or response to treatment (on imaging or clinical assessment)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age greater than or equal to 18 years\n* ECOG from 0 to 2\n* Histological diagnosis of Lobular Carcinoma of the breast based on a breast biopsy\n* Patient na\u00efve to any treatment for lobular breast carcinoma\n* Women of childbearing age should have an adequate method of contraception\n* Patient having voluntarily accepted to participate in the study and signed the informed consent\n* Minimum tumor stage IIA\n* Sufficient histological material in the biopsy or the surgical specimen, if the biopsy is insufficient\n\nExclusion Criteria:\n\n* PET scan contraindications: severe claustrophobia, unbalanced diabetes during 18F-FDG PET scans (fasting capillary blood sugar \u2265 11 mmol)\n* Hormone therapy started\n* 18F-FDG PET scan \\> 21 days\n* Pregnant women, parturients and nursing mothers\n* Persons deprived of liberty by a judicial or administrative decision\n* Persons admitted to a health or social establishment for purposes other than research\n* Adults who are the subject of a legal protection measure or who are unable to express their consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}